Australasian COVID-19 Trial

ASCOT is a clinical trial that will generate clinical evidence about treatment for COVID-19 that can be applied during the pandemic to reduce mortality or the need for mechanical ventilation in hospitalised but not yet critically ill patients with COVID-19.

Trial Overview

1606 patients enrolled in trial

1606 patients randomised

23 sites activated


The ASCOT Process